ArticleBritish journal of cancer2009

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

F Loupakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.